Stay ahead of the latest BioPharma trends and industry insights
Pharma U.S. Manufacturing Moment: Where Companies are Making the Biggest Moves
Source: PharmaVoice
The tariff war has prompted new calls to reshore manufacturing. Several large organizations have already made the leap as BioPharma leverages technological advances such as continuous manufacturing, AI-enabled processes, robotics and automation have brought labor costs down, and regulators are offering more support.
U.S. FDA to Phase Out Animal Testing in Drug Development
Source: Reuters
The U.S. FDA plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with “human-relevant methods,” including the use of AI-based models. The new approach would help improve drug safety, as well as lower R&D costs and drug prices.
Rewriting the R&D Playbook to Account for Shifts in the Investment Landscape
Source: PharmaVoice
A recent Deloitte report highlights the significant shift in Big Pharma’s R&D investment strategies with industry returns rising to 5.9% for the top 20 BioPharma companies.
